NCT00143702View on ClinicalTrials.gov

D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Acidosis, Lactic
Interventions
DRUG

d4T

See Detailed Description.

DRUG

Abacavir

See Detailed Description.

DRUG

Riboflavin and Thiamine (Supplementation)

See Detailed Description.

Trial Locations (2)

V6Z 1Y6

St. Paul's Hospital, Vancouver

Unknown

Positive Care Clinic, Toronto

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

CIHR Canadian HIV Trials Network

NETWORK

lead

University of British Columbia

OTHER

NCT00143702 - D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE) | Biotech Hunter | Biotech Hunter